Testicular Cancer and Paraneoplastic Encephalitis: A Review of the Current Literature.

Immunotherapy for paraneoplastic syndromes Neuro-oncology Onconeural antibodies Paraneoplastic encephalitis Testicular cancer

Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 27 02 2024
revised: 28 04 2024
accepted: 28 04 2024
medline: 1 6 2024
pubmed: 1 6 2024
entrez: 31 5 2024
Statut: aheadofprint

Résumé

Paraneoplastic encephalitis (PE) represents a rare but significant complication in patients with testicular cancer (TC). Given the paucity of comprehensive literature on this topic, our review seeks to consolidate current knowledge and provide evidence-based recommendations for the diagnosis, prognosis, and management of PE in the context of TC. In adherence to PRISMA guidelines, a systematic literature review was conducted from 1950 to April 2024 using PubMed. The search focused on articles where TC was identified as the primary etiology of PE. The Mixed Methods Appraisal Tool and the Oxford Centre for Evidence-Based Medicine's levels of evidence tool were employed for assessing study quality, and a thematic analysis was conducted to identify trends and patterns. Out of 91 articles identified, 29 met the inclusion criteria, encompassing 5 retrospective chart reviews, 3 case series, and 22 case reports. Findings indicate that PE symptoms can manifest at any stage of TC-before tumor detection, during treatment, or even years posttreatment. A notable observation was the frequent oversight of microscopic testicular tumors in ultrasound imaging, leading to diagnostic delays. The outcomes of PE in the context of TC were diverse, reflecting the heterogeneity of the studies included. PE, although rare, is a critical consideration in patients with TC presenting with neuropsychiatric symptoms. Early recognition and appropriate diagnostic workup, including consideration for microscopic neoplasms, are essential for timely intervention and improved patient outcomes.

Identifiants

pubmed: 38820998
pii: S1558-7673(24)00082-X
doi: 10.1016/j.clgc.2024.102111
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102111

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Auteurs

Ekamjit Singh Deol (ES)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO. Electronic address: ekamjit.deol@health.slu.edu.

Awais Paracha (A)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Maria Paracha (M)

Department of Biology, University of Virginia, Charlottesville, VA.

Omar Moussa Pasha (O)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Esed Mustafic (E)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Regan Davis (R)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Zohair Siddiqui (Z)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Ali Abid (A)

Department of Biology, Saint Louis University, Saint Louis, MO.

Umar Durrani (U)

Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.

Wilson Rodriguez (W)

Department of Neurology and Psychiatry, Saint Louis University School of Medicine, St. Louis, MO.

Xinhua Zhu (X)

Division of Medical Oncology & Hematology, Northwell Health Cancer Institute, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY.

Zachary Hamilton (Z)

Division of Urology, Department of Surgery, Saint Louis University School of Medicine, Saint Louis, MO.

Classifications MeSH